Latest Breaking News On - Animas corporation - Page 2 : comparemela.com

The Disposable Insulin-Delivery Device Market is expected to be worth US$ 15,780.6 million in 2023, with a compound annual growth rate (CAGR) of 7.6% between 2023 and 2033, for a total market worth US$ 32,814 million. This expansion is mostly driven by an increase in diabetes-related health spending in developing co.

United statesUnited kingdomNew yorkEli lillyEyesense gmbInternational diabetes federationAbbott laboratoriesAnimas corporationBeta bionics incNovo nordiskInsulet corpGreater new york chamberZyla healthMedtronic plcTandem diabetes care incValeritas inc